3 days of β-lactam therapy is non-inferior to 8 days of therapy among patients with community-acquired pneumonia
1. Cure at 15 days occurred in 77% of patients in the placebo (3-day therapy) group compared to 68% of ...
Tag: community acquired pneumonia
#VisualAbstract: Short-course antimicrobial therapy effective for pediatric community-acquired pneumonia
1. Five-day treatment of community-acquired pneumonia in children was comparable to standard, 10-day treatment. Evidence Rating Level: 2 (Good) Community-acquired pneumonia ...
Proadrenomedullin predicts severe community-acquired pneumonia among children
1. Among children with community-acquired pneumonia, proadrenomedullin more accurately predicted severe disease than established biomarkers such as C-reactive protein and ...
Biomarkers obtained in the ED show limited utility in predicting pneumonia severity in children
1. In a study of children with community acquired pneumonia, initial biomarker levels (C-reactive protein, white blood cell count, procalcitonin, ...
#VisualAbstract: Oral Lefamulin vs Moxifloxacin for Early Clinical Response Among Adults With Community-Acquired Bacterial Pneumonia
1. In this randomized controlled trial, oral lefamulin was noninferior to oral moxifloxacin for treating community-acquired pneumonia, with regards to ...
Lefamulin noninferior to moxifloxacin for community-acquired pneumonia
1. In this randomized controlled trial, oral lefamulin was noninferior to oral moxifloxacin for treating community-acquired pneumonia, with regards to ...
Omadacycline is noninferior to moxifloxacin in treating community acquired bacterial pneumonia
1. Intensive care unit (ICU) hospitalized adults with community acquired bacterial pneumonia had comparable clinical responses when taking antibiotic courses ...
